AMS · American Shared Hospital Services - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.08M | - | $7.17M | $7.07M | $6.11M | - | $7.00M | $7.06M | $5.22M | - |
| Cost of Revenue | $5.80M | - | $5.63M | $5.44M | $5.17M | - | - | $4.59M | $3.07M | - |
| Gross Profit | $1.29M | - | $1.59M | $1.63M | $942.0K | - | $1.37M | $2.47M | $2.14M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $1.91M | - | $1.54M | $1.75M | $1.81M | - | $1.92M | $1.90M | $1.88M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $1.29M | - | $1.45M | $1.51M | $1.45M | - | $1.64M | $1.52M | $1.33M | - |
| Operating Income | ($924.0K) | - | ($344.0K) | ($544.0K) | ($1.30M) | - | ($889.0K) | ($1.0K) | ($85.0K) | - |
| Interest Expense | $302.0K | - | $392.0K | $428.0K | $433.0K | - | $336.0K | $385.0K | $349.0K | - |
| Income Tax | $92.0K | - | $48.0K | ($21.0K) | ($323.0K) | - | ($169.0K) | ($31.0K) | ($44.0K) | - |
| Net Income | ($612.0K) | - | ($17.0K) | ($280.0K) | ($625.0K) | - | ($207.0K) | $3.60M | $119.0K | - |
| EPS - Basic | ($0.09) | - | $0.00 | ($0.04) | ($0.10) | - | ($0.03) | $0.56 | $0.02 | - |
| EPS - Diluted | ($0.09) | - | $0.00 | ($0.04) | ($0.10) | - | ($0.03) | $0.55 | $0.02 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.97M | $3.46M | $5.09M | $11.08M | $11.24M | $11.03M | $13.83M | $14.24M | $12.79M | $13.69M |
| Accounts Receivable | $10.57M | $10.52M | $11.81M | $9.58M | $8.74M | $11.61M | $8.63M | $8.61M | $6.43M | $4.34M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $1.08M | $607.0K | $1.11M | $806.0K | $1.23M | $1.56M | $1.79M | $859.0K | $267.0K | $315.0K |
| Current Assets | $18.27M | $17.72M | $20.59M | $24.43M | $23.74M | $26.26M | $25.72M | $25.64M | $21.36M | $20.46M |
| Total Assets | $54.73M | $55.48M | $59.63M | $63.49M | $63.31M | $60.20M | $63.27M | $60.83M | $50.12M | $48.16M |
| Current Liabilities | $23.72M | $23.44M | $17.17M | $20.86M | $12.71M | $10.40M | $17.56M | $13.34M | $10.78M | $10.78M |
| Long-term Debt | $16.84M | $0 | $8.63M | $9.22M | $16.80M | $17.34M | $10.82M | $12.05M | $12.89M | $11.04M |
| Total Liabilities | $28.02M | $27.79M | $31.03M | $34.65M | $34.10M | $30.17M | $31.44M | $28.47M | $23.74M | $21.88M |
| Stockholders' Equity | $23.52M | $24.03M | $24.57M | $24.48M | $24.65M | $25.18M | $26.42M | $26.54M | $22.84M | $22.62M |
| Retained Earnings | $3.65M | $4.26M | $4.89M | $4.91M | $5.19M | $5.82M | $7.14M | $7.35M | $3.75M | $3.63M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.15M | - | - | - | $2.50M | - | - | - | ($1.86M) | - |
| Investing Cash Flow | ($41.0K) | - | - | - | ($4.01M) | - | - | - | ($1.18M) | - |
| Financing Cash Flow | ($597.0K) | - | - | - | $1.73M | - | - | - | $2.28M | - |
| CapEx | $41.0K | - | - | - | $4.01M | - | - | - | $1.18M | - |
| Free Cash Flow | $2.11M | - | - | - | ($1.51M) | - | - | - | ($3.05M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 18.2% | - | 22.1% | 23.1% | 15.4% | - | 19.6% | 35.0% | 41.1% | - |
| Operating margin | -13.0% | - | -4.8% | -7.7% | -21.3% | - | -12.7% | -0.0% | -1.6% | - |
| EBITDA margin | 5.2% | - | 15.5% | 13.6% | 2.5% | - | 10.8% | 21.6% | 23.9% | - |
| Net margin | -8.6% | - | -0.2% | -4.0% | -10.2% | - | -3.0% | 51.0% | 2.3% | - |
| Free cash flow margin | 29.8% | - | - | - | -24.7% | - | - | - | -58.4% | - |
| FCF / Net income | -3.44 | - | - | - | 2.42 | - | - | - | -25.61 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 27.0% | - | 21.4% | 24.7% | 29.6% | - | 27.5% | 26.9% | 36.0% | - |
| Effective tax rate | - | - | 154.8% | - | - | - | - | -0.9% | -58.7% | - |
| Return on assets | -1.1% | - | -0.0% | -0.4% | -1.0% | - | -0.3% | 5.9% | 0.2% | - |
| Return on equity | -2.6% | - | -0.1% | -1.1% | -2.5% | - | -0.8% | 13.6% | 0.5% | - |
| Return on invested capital | -1.8% | - | -0.5% | -1.3% | -2.5% | - | -1.9% | -0.0% | -0.2% | - |
| Liquidity | ||||||||||
| Current ratio | 0.77 | 0.76 | 1.20 | 1.17 | 1.87 | 2.52 | 1.46 | 1.92 | 1.98 | 1.90 |
| Quick ratio | 0.77 | 0.76 | 1.20 | 1.17 | 1.87 | 2.52 | 1.46 | 1.92 | 1.98 | 1.90 |
| Cash ratio | 0.21 | 0.15 | 0.30 | 0.53 | 0.88 | 1.06 | 0.79 | 1.07 | 1.19 | 1.27 |
| Leverage | ||||||||||
| Debt / Equity | 0.72 | 0.00 | 0.35 | 0.38 | 0.68 | 0.69 | 0.41 | 0.45 | 0.56 | 0.49 |
| Debt / Assets | 0.31 | 0.00 | 0.14 | 0.15 | 0.27 | 0.29 | 0.17 | 0.20 | 0.26 | 0.23 |
| Debt / EBITDA | 45.52 | - | 7.78 | 9.57 | 111.99 | - | 14.33 | 7.92 | 10.32 | - |
| Interest coverage | -3.1x | - | -0.9x | -1.3x | -3.0x | - | -2.6x | -0.0x | -0.2x | - |
| Equity multiplier | 2.33 | 2.31 | 2.43 | 2.59 | 2.57 | 2.39 | 2.39 | 2.29 | 2.19 | 2.13 |
| Liabilities / Assets | 0.51 | 0.50 | 0.52 | 0.55 | 0.54 | 0.50 | 0.50 | 0.47 | 0.47 | 0.45 |
| Efficiency | ||||||||||
| Asset turnover | 0.13 | - | 0.12 | 0.11 | 0.10 | - | 0.11 | 0.12 | 0.10 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 544d | - | 601d | 494d | 522d | - | 450d | 445d | 450d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 68d | - | 72d | 54d | 87d | - | - | 68d | 32d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 15.9% | - | 2.5% | 0.2% | 17.2% | - | 36.3% | 26.7% | 5.9% | - |
| Revenue CAGR (3y) | 12.9% | - | 14.1% | 12.0% | 8.0% | - | 19.5% | 16.4% | 6.1% | - |
| Revenue CAGR (5y) | 10.2% | - | - | 8.7% | 6.0% | - | 5.7% | 6.4% | -0.3% | - |
| Gross profit growth (YoY) | 36.7% | - | 15.8% | -34.0% | -56.0% | - | -34.8% | -2.0% | 12.3% | - |
| Operating income growth (YoY) | 28.9% | - | 61.3% | -54300.0% | -1428.2% | - | - | 99.7% | - | - |
| Net income growth (YoY) | 2.1% | - | 91.8% | - | - | - | - | - | -36.7% | - |
| EPS growth (YoY) | 10.0% | - | - | - | - | - | - | - | -33.3% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | 122.9% | -16.7% | - |
| FCF growth (YoY) | - | - | - | - | 50.4% | - | - | - | - | - |
| FCF CAGR (5y) | 4.2% | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -4.6% | -4.6% | -7.0% | -7.8% | 7.9% | 11.3% | 19.5% | 21.2% | 4.3% | 4.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$28.08M totalDirect Patient Services$15.53M · 55.3%
Medical Equipment Leasing$12.55M · 44.7%
Product / service
$28.08M totalPatient Income$15.53M · 55.3%
Rental Income From Medical Services$12.55M · 44.7%
Peer comparison
Same SIC group: Services-Medical Laboratories
Comparing AMERICAN SHARED HOSPITAL SERVICES against the 5 most active filers in the same SIC group.